Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment

Table 3 Multivariate analysis of independent risk factor for overall survival in patients who underwent DCS therapy

	HR	95%CI	p
Multivariate analysis with NLR
Yoshida classification category 1/2	1.652	0.774–3.524	0.193
Albumin	0.522	0.369–1.656	0.522
NLR	1.720	0.897–3.295	0.102
CD8⁺ lymphocyte	0.589	0.211–1.640	0.311
CD163⁺ macrophage	2.281	1.017–5.117	0.045
Multivariate analysis with LMR
Yoshida classification category 1/2	1.980	0.915- 4.278	0.082
Albumin	0.842	0.397- 1.784	0.654
LMR	0.482	0.212–1.095	0.081
CD8⁺ lymphocyte	0.555	0.197- 1.563	0.265
CD163⁺ macrophage	1.945	1.018–3.713	0.043

95%CI 95% confidence interval, HR Hazard ratio, NLR, Neutrophil to lymphocyte ratio, LMR Lymphocyte to monocyte ratio

ISSN: 1471-2407